Patents by Inventor Dodanim Talavera-Adame

Dodanim Talavera-Adame has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11920160
    Abstract: Production of beta-cells from stem cells from pluripotent stem cells have always been significantly lacking in at least one of the following properties: 1) functional properties related to insulin-production and glucose signaling response, 2) mature phenotype such as biochemical markers or cell structures, 3) efficiency in production of differentiated cells. Described herein is multistep differentiation protocol which substantially overcomes all of the existing limitations. Pluripotent stem cells, including induced pluripotent stem cells (iPSCs), and embryonic stem cells (ESCs) can be differentiated using an embryoid body (EB) formation step, followed by B maturation via endothelial cells (EC) co-culturing and incubation with a sequential series of bone morphogenic protein (BMP)-related growth factor cocktails. The resulting cells displayed functional properties, including insulin-production and glucose signaling response, and mature phenotype of C-peptide expression.
    Type: Grant
    Filed: February 21, 2014
    Date of Patent: March 5, 2024
    Assignee: Cedars-Sinai Medical Center
    Inventors: Dodanim Talavera-Adame, Donald C. Dafoe
  • Patent number: 11473117
    Abstract: A technology regarding the production, formulation and use of conditioned media and the factors included therein is disclosed. The conditioned media may be inoculated with animal cells, plant cells and any combination thereof. The inoculations may occur simultaneous or at different times. Cells retrieved from different areas of the animal and/or the plant may also be cultured together to form conditioned media and associated growth factors.
    Type: Grant
    Filed: July 23, 2019
    Date of Patent: October 18, 2022
    Assignee: Rinati Skin, LLC
    Inventors: Nathan Newman, Alex Rajangam, Dodanim Talavera-Adame, Harpreet Sidhu
  • Publication number: 20200316169
    Abstract: A technology regarding the production, formulation and use of conditioned media and the factors included therein is disclosed. The conditioned media may be inoculated with animal cells, plant cells and any combination thereof. The inoculations may occur simultaneous or at different times. Cells retrieved from different areas of the animal and/or the plant may also be cultured together to form conditioned media and associated growth factors.
    Type: Application
    Filed: April 2, 2020
    Publication date: October 8, 2020
    Inventors: Nathan Newman, Alex Rajangam, Dodanim Talavera-Adame, Harpreet Sidhu
  • Publication number: 20200056217
    Abstract: A technology regarding the production, formulation and use of conditioned media and the factors included therein is disclosed. The conditioned media may be inoculated with animal cells, plant cells and any combination thereof. The inoculations may occur simultaneous or at different times. Cells retrieved from different areas of the animal and/or the plant may also be cultured together to form conditioned media and associated growth factors.
    Type: Application
    Filed: July 23, 2019
    Publication date: February 20, 2020
    Applicant: Rinati Skin LLC
    Inventors: Nathan Newman, Alex Rajangam, Dodanim Talavera-Adame, Harpreet Sidhu
  • Publication number: 20150376574
    Abstract: Production of beta-cells from stem cells from pluripotent stem cells have always been significantly lacking in at least one of the following properties: 1) functional properties related to insulin-production and glucose signaling response, 2) mature phenotype such as biochemical markers or cell structures, 3) efficiency in production of differentiated cells. Described herein is multistep differentiation protocol which substantially overcomes all of the existing limitations. Pluripotent stem cells, including induced pluripotent stem cells (iPSCs), and embryonic stem cells (ESCs) can be differentiated using an embryoid body (EB) formation step, followed by B maturation via endothelial cells (EC) co-culturing and incubation with a sequential series of bone morphogenic protein (BMP)-related growth factor cocktails. The resulting cells displayed functional properties, including insulin-production and glucose signaling response, and mature phenotype of C-peptide expression.
    Type: Application
    Filed: February 21, 2014
    Publication date: December 31, 2015
    Applicant: CEDARS-SINAI MEDICAL CENTER
    Inventors: Dodanim Talavera-Adame, Donald C. Dafoe